Razor Genomics
Pre-clinicalRiskReveal™ is a molecular stratification test to identify patients with IA-IIA non-squamous non-small cell lung cancer (NSCLC) who may be at low- or high-risk of having a recurrence (1).
Founded
2009
Focus
Diagnostics
About
RiskReveal™ is a molecular stratification test to identify patients with IA-IIA non-squamous non-small cell lung cancer (NSCLC) who may be at low- or high-risk of having a recurrence (1).
Funding History
2Total raised: $2.5M
Seed$2MUndisclosedFeb 15, 2020
Grant$500KNIH SBIRJun 15, 2018
Company Info
TypePrivate
Founded2009
LocationNashville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile